Objective Benchmarking has been proposed to reflect surgical quality and represents the
highest standard reference values for desirable results. We sought to determine benchmark …

Introduction: Optimizing patient safety and quality improvement is increasingly important in
surgery. Benchmarks and clinical quality registries are being developed to assess the best …

OBJECTIVE Recent trials for temporal lobe epilepsy (TLE) highlight the challenges of
investigating surgical outcomes using randomized controlled trials (RCTs). Although several …

Objectives To investigate the long-term postoperative outcomes and predictive factors
associated with poor surgical outcomes in mesial temporal lobe epilepsy (MTLE). Materials …

Pharmacoresistant epilepsy develops in approximately 25% to 30% of all epilepsy patients.
1 Mesial temporal lobe epilepsy (MTLE) patients tend to be most refractory to treatment with …

Objective Epilepsy surgery is the most effective treatment for select patients with drug‐
resistant epilepsy. In this article, we aim to provide an accurate understanding of the current …

Objective To evaluate the effectiveness of anterior temporal lobectomy (ATL) versus
selective amygdalohippocampectomy (SAH) on seizure-free outcome in patients with …

BACKGROUND Cortico-amygdalohippocampectomy (CAH) is effective for mesial temporal
lobe epilepsy (mTLE). Concerns regarding surgical morbidity have generated enthusiasm …

Purpose: To describe the trial design for the multicenter Early Randomized Surgical
Epilepsy Trial (ERSET). Patients with pharmacoresistant epilepsy are generally referred for …

Purpose: To review the recent advances in the field of temporal lobe epilepsy (TLE) surgery.
Results: TLE surgery has recently demonstrated a highly significant superiority over optimal …